Barclays PLC Sells 27,508 Shares of Global Medical REIT Inc. (NYSE:GMRE)

Barclays PLC lowered its stake in Global Medical REIT Inc. (NYSE:GMRE) by 17.9% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 126,543 shares of the company’s stock after selling 27,508 shares during the period. Barclays PLC owned 0.19% of Global Medical REIT worth $978,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in GMRE. Franklin Resources Inc. increased its stake in Global Medical REIT by 228.9% during the 3rd quarter. Franklin Resources Inc. now owns 114,988 shares of the company’s stock valued at $1,073,000 after purchasing an additional 80,030 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in shares of Global Medical REIT by 54.3% during the third quarter. JPMorgan Chase & Co. now owns 231,927 shares of the company’s stock valued at $2,298,000 after buying an additional 81,596 shares during the last quarter. SG Americas Securities LLC increased its position in shares of Global Medical REIT by 13.8% during the fourth quarter. SG Americas Securities LLC now owns 25,828 shares of the company’s stock valued at $199,000 after acquiring an additional 3,128 shares in the last quarter. Janney Montgomery Scott LLC raised its holdings in Global Medical REIT by 11.3% in the 4th quarter. Janney Montgomery Scott LLC now owns 143,447 shares of the company’s stock worth $1,107,000 after acquiring an additional 14,532 shares during the last quarter. Finally, Hodges Capital Management Inc. lifted its position in Global Medical REIT by 37.8% in the 4th quarter. Hodges Capital Management Inc. now owns 31,000 shares of the company’s stock valued at $239,000 after acquiring an additional 8,500 shares in the last quarter. Institutional investors own 57.52% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, B. Riley assumed coverage on Global Medical REIT in a report on Thursday, April 3rd. They issued a “neutral” rating and a $9.00 target price for the company.

Global Medical REIT Stock Down 1.0 %

GMRE opened at $7.74 on Tuesday. The stock has a market capitalization of $517.25 million, a price-to-earnings ratio of -386.56, a PEG ratio of 1.43 and a beta of 1.23. The firm has a 50 day moving average price of $8.12 and a 200-day moving average price of $8.28. Global Medical REIT Inc. has a twelve month low of $6.75 and a twelve month high of $10.46. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 1.26.

Global Medical REIT (NYSE:GMRE) last announced its earnings results on Thursday, February 27th. The company reported $0.22 earnings per share for the quarter, beating analysts’ consensus estimates of $0.01 by $0.21. The business had revenue of $35.16 million during the quarter, compared to analyst estimates of $34.87 million. Global Medical REIT had a net margin of 3.23% and a return on equity of 0.86%. Equities research analysts forecast that Global Medical REIT Inc. will post 0.81 earnings per share for the current year.

Global Medical REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 9th. Shareholders of record on Friday, March 21st were given a $0.21 dividend. The ex-dividend date of this dividend was Friday, March 21st. This represents a $0.84 annualized dividend and a yield of 10.86%. Global Medical REIT’s payout ratio is 8,400.00%.

About Global Medical REIT

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.